173952-37-9

Upstream product

• 2139-43-7 5-bromo-6-(1,3-dioxolan-2-yl)benzo[d][1,3]dioxolane 

Downstream Products

• 173952-38-0 1-(4-acetylaminophenyl)-6,7-methylenedioxyphthalazine 
• 186252-78-8 4-(4-acetylaminophenyl)-1,2-dihydro-2-(N,N-dimethylcarbamoyl)-1-methyl-6,7-methylendioxyphthalazine 
• 1026181-98-5 8-(4-Acetylamino-phenyl)-5-methyl-5H-[1,3]dioxolo[4,5-g]phthalazine-6-carboxylic acid butylamide 
• 1027275-83-7 N-[4-(8-Methyl-7-propylthiocarbamoyl-7,8-dihydro-[1,3]dioxolo[4,5-g]phthalazin-5-yl)-phenyl]-acetamide 
• 186252-57-3 4-(4-Acetylaminophenyl)-1,2-dihydro-1-methyl-2-propylcarbamoyl-6,7-methylendioxyphthalazine 
• 186252-55-1 4-(4-Acetylaminophenyl)-1,2-dihydro-2-(N-ethylcarbamoyl)-1-methyl-6,7-methylendioxyphthalazine 
• 186252-58-4 8-(4-Acetylamino-phenyl)-5-methyl-5H-[1,3]dioxolo[4,5-g]phthalazine-6-carboxylic acid isopropylamide 
• 186252-53-9 8-(4-Acetylamino-phenyl)-5-methyl-5H-[1,3]dioxolo[4,5-g]phthalazine-6-carboxylic acid methylamide 
• 173952-44-8 SYM 2206 

Relevant academic research and scientific papers

1-arylphthalazine antagonists of excitatory amino acid receptors

Substituted 1-arylphthalazine compositions with the formula wherein R1, R2, R3 and R4 are independently a) H, b) HO, c) R11O-, d) halogen, e) C1-C3-alkyl, f) CF3, g) R12CO2-, or h) R12CONH-; R1 and R2, or R2 and R3, or R3 and R4 can be taken together to b

Dihydrophthalazine antagonists of excitatory amino acid receptors

Substituted dihydrophthalazine compositions are provided which are active as non-NMDA ionotropic excitatory amino acid (EAA) receptor antagonists. The compositions are useful for treating disorders associated with excessive activation of the non-NMDA subt